A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells
Cellular Oncology · 2024
DOI: 10.1007/s13402-024-00971-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Zhifeng Yan und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin Key Laboratory of Cell Therapy for Blo…. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Leukemia, Myeloid, Acute, Sialic Acid Binding Ig-like Lectin 3, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematolo…
- Tianjin Institutes of Health Science, Tianjin, 301617, China.
- The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
- Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
- Tianjin Institutes of Health Science, Tianjin, 301617, China. wangjxm@ihcams.ac.cn.
- Tianjin Institutes of Health Science, Tianjin, 301617, China. wangjx@ihcams.ac.cn.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Yan, Z., Gu, R., Ma, H., Chen, N., Zhang, T., Xu, Y., Qiu, S., Xing, H., Tang, K., Tian, Z., Rao, Q., Wang, M., & Wang, J. (2024). A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells. Cellular Oncology. https://doi.org/10.1007/s13402-024-00971-5
Vancouver
Yan Z, Gu R, Ma H, Chen N, Zhang T, Xu Y, et al. A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells. Cellular Oncology. 2024. doi:10.1007/s13402-024-00971-5
BibTeX
@article{Yan2024,
author = {Yan, Zhifeng and Gu, Runxia and Ma, Haotian and Chen, Nianci and Zhang, Ting and Xu, Yingxi and Qiu, Shaowei and Xing, Haiyan and Tang, Kejing and Tian, Zheng and Rao, Qing and Wang, Min and Wang, Jianxiang},
title = {A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells},
journal = {Cellular Oncology},
year = {2024},
doi = {10.1007/s13402-024-00971-5}
}
EUVIMED